Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01MA12	LOXOF	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet, film coated	141,103 L.L
M01AH05	COXIFLAM	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,293,928 L.L
N02BE01	PARA-DENK 125 SUPPOS.	G	Paracetamol - 125mg	125mg	Suppository	190,826 L.L
N05AE05	LAROZA	G	Lurasidone - 120mg	120mg	Tablet, film coated	5,548,726 L.L
R03BA02	CORTAIR	G	Budesonide - 1mg/2ml	0.5mg/ml	Inhalation suspension for nebuliser	1,209,458 L.L
A10BH01	SITAGLIPTINE ARROW	G	Sitagliptin - 100mg	100mg	Tablet, coated	1,154,361 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	606,649 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	451,531 L.L
C09CA03	ARBITEN 160	G	Valsartan - 160mg	160mg	Tablet	544,256 L.L
C10AA05	JOSWE ATORVAST 40	G	Atorvastatin - 40mg	40mg	Caplet, film coated	1,327,716 L.L
D08AX02	EOSIN ALCOHOLIC	G	Eosin - 1%	1%	Solution	108,787 L.L
G04BE08	VIVIDA 5	G	Tadalafil - 5mg	5mg	Tablet, film coated	2,559,700 L.L
J01MA12	MATADOR	G	Levofloxacin - 500mg	500mg	Tablet, film coated	787,492 L.L
M01AH05	ETOXA	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,293,928 L.L
N02BE01	SULDEX 125	G	Paracetamol - 125mg	125mg	Suppository	110,067 L.L
N06AX26	LYTIOX	G	Vortioxetine - 10mg	10mg	Tablet, film coated	2,064,142 L.L
R03BA02	BUDECORT	G	Budesonide - 1mg	1mg	Respule	1,226,928 L.L
A10BH01	SITAGLIPTINE ARROW	G	Sitagliptin - 50mg	50mg	Tablet, coated	1,139,578 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,439,255 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
C03CA01	FUROSEMIDE SALF	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	216,359 L.L
C09CA03	TABUVAN	G	Valsartan - 160mg	160mg	Tablet, film coated	544,256 L.L
C10AA05	LIPODAR	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	2,412,197 L.L
D08AX02	EOSIN AQUEUSE	G	Eosin - 1%	1%	Solution	84,470 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 10mg	10mg	Tablet	888,280 L.L
J01DC02	AXETINE	G	Cefuroxime sodium - 750mg	750mg	Injectable powder for solution	1,193,332 L.L
J01MA12	OXALEV	G	Levofloxacin - 500mg	500mg	Tablet, film coated	791,523 L.L
M01AH05	ETOXA	G	Etoricoxib - 90mg	90mg	Tablet, film coated	431,309 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L